CMNDClearmind Medicine Inc.

Nasdaq clearmindmedicine.com


$ 1.29 $ 0.03 (2.38 %)    

Thursday, 05-Sep-2024 15:00:41 EDT
QQQ $ 459.86 $ 0.43 (0.09 %)
DIA $ 407.95 $ -1.96 (-0.48 %)
SPY $ 548.56 $ -1.34 (-0.24 %)
TLT $ 99.56 $ 0.56 (0.57 %)
GLD $ 232.35 $ 1.92 (0.83 %)
$ 1.29
$ 1.24
$ 1.28 x 100
$ 1.30 x 100
$ 1.24 - $ 1.31
$ 0.92 - $ 16.19
62,551
na
783,465
$ -0.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 could-psychedelics-end-binge-drinking-a-breakthrough-patent-says-yes

Clearmind Medicine secures a U.S. patent for its MEAI-based binge behavior treatment, marking a significant advancement in addr...

 clearmind-medicine-yissum-expand-collaboration-with-submission-of-international-patent-application-for-generation-30-psychedelic-compounds-to-treat-mental-disorders

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "company"), a biotech company focused on...

Core News & Articles

SciSparc has been collaborating with Clearmind Medicine to create effective treatments for obesity and metabolic syndrome by co...

 clearmind-medicine-inks-pact-to-source-manufacturers-and-distributors-for-its-alcohol-substitute-beverage-product

This partnership aims to source global manufacturers and distributors for Clearmind's groundbreaking MEAI-based alcohol sub...

 clearmind-medicine-granted-patent-approval-in-hong-kong-for-its-binge-behaviors-treatment

- Reuters 

 why-psychedelic-pharma-clearmind-medicine-stock-is-moving-higher

Clearmind Medicine shares are trading higher Friday after the company announced advancement in its proprietary MEAI-based binge...

 whats-going-on-with-clearmind-medicine-stock-tuesday

Clearmind said its alcohol substitute was granted patents in the U.S., India and Europe. The company also highlighted that the ...

Core News & Articles
Market-Moving News for June 11th
06/11/2024 12:29:09

MOLN: 11% | Molecular Partners shares are trading higher after the company announced the debut of their lead Raido-DARPin thera...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION